Market Overview

Novo Nordisk Posts 35% Rise In Q3 Profit, Lifts 2012 Forecast

Related NVO
Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest EPS
Novo Nordisk Diabetes Drug Xultophy Gets Positive CHMP View
Novo Nordisk Upgraded to 'Buy' (Fox Business)

Novo Nordisk A/S (NYSE: NVO) reported a 35% rise in its third-quarter net profit and lifted its full-year earnings forecast.

Novo Nordisk's quarterly net profit surged to DKK5.67 billion, from DKK4.20 billion, in the year-ago period. However, analysts were expecting a profit of DKK5.27 billion.

Novo Nordisk shares closed at $161.29 yesterday.

Posted-In: profitEarnings News Guidance


Most Popular

Related Articles (NVO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters